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This thesis deals with derivatives of pyrazine-2-carboxylic (POA) acid with potential antimycobacterial 
activity. In the theoretical part of the thesis there is a short description of tuberculosis (TB) disease, 
discussion of its epidemiology an associated risk factors of increasing resistance to fist-line antituberculars 
and the co-infection with HIV. Antituberculars used in clinical practice are described as well as the summary 
of new antituberculars under clinical trials is presented. Pyrazinamide (PZA) as one of the most important 
first-line antituberculars is in the focus of this thesis. Multiple up-to-date theories of PZA (POA) mechanism of 
action are described and discussed. Importantly, a summary of structural changes of PZA/POA attempted in 
the past to prepare new antituberculars is presented and the importance and relevance of individual 
structural changes is discussed. 
In the practical part of this thesis, 76 derivatives of PZA/POA were prepared, 68 of them were new 
compounds not described in the scientific literature. The prepared compounds fall into several groups of 
pyrazin-2-carboxylic acid anilides, non-aromatically N-substituted 6-amino-5-cyanopyrazine-2-carboxamides 
and 3-aminopyrazine-2,5-dicarbonitriles, 3-(benzylamino)-5-cyanopyrazine-2-carboxamides and 
3-(benzylamino)pyrazine-2,5-dicarbonitriles. All prepared compounds were tested for in vitro 
antimycobacterial activity against Mycobacterium tuberculosis H37Rv and most of them against M. kansasii 
and two different strains of M avium as well. In all of the structural groups proposed above, at least some 
compounds exerted activity of PZA or slightly better (MIC = 6,25 – 25 μg/mL against M. tuberculosis). Few 
compounds were active even against the strains of M. kansasii and M. avium. The relationships between the 
structure and antimycobacterial activity are discussed within the series of compounds with the respect to 
previously prepared analogues of similar structure. 
Some of the compounds were tested even for antifungal and antibacterial activity against selected human 
pathogens. None of the tested compounds exerted any antibacterial activity. Antifungal activity was 
negligible with few exceptions. 
The results of this doctoral thesis contribute to the long-term research objectives of the Dpt. of 
Pharmaceutical Chemistry and Drug Control focused on the development of new potential antituberculars 
derived from PZA (POA). 
